Research News

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression

Intestinal metaplasia (IM), often symptomless, poses a six-fold increased risk of stomach cancer. In this cross-institutional study, co-led by N2CR member Prof Jimmy So, researchers have identified 26 IM driver genes pivotal in the transition to cancer. The findings, published in Cancer Cell, was the world’s largest genomic survey of over 1,100 samples of IM. This significant discovery offers insight into the processes that control the transformation to stomach cancer, providing a crucial opportunity for early detection and focused prevention.

Read more: https://pubmed.ncbi.nlm.nih.gov/37890493/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

ZBTB48: A New On-Switch for the Immune Response

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections and cancer …

Read More →
Research News

Magnetic Field Therapy Improves Breast Cancer Treatment with Fewer Side Effects

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire body, which, …

Read More →
Research News

Extracellular Vesicles: Key Players in Tumour Microenvironment and Drug Resistance

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the …

Read More →